Neurology Billing and Coding Services
Neurology Governance Built for Procedure and Monitoring Complexity
Neurology billing complexity derives from high-value diagnostic procedures with time-based coding, multi-component testing bundles, and documentation requirements that payers interpret inconsistently. Electromyography and nerve conduction studies (95860-95886) code based on extremity count, number of muscles tested, and time intervals between individual components. A single EMG/NCS encounter may include initial evaluation, motor nerve conduction studies, sensory nerve conduction studies, needle electromyography, and interpretation. When billing staff apply routine visit codes to what should be procedure-based time coding, claims underbill by 40-60%. Continuous EEG monitoring (95950-95963) carries bundling complexity where the interpretation and report code differs from the initial setup and monitoring codes, creating confusion about component separation. Botox injection coding for migraine (96800-96820) carries FDA indication restrictions that payers enforce strictly, with off-label use systematically denied regardless of clinical appropriateness.
QWay Healthcare deploys certified neurology coders who understand time-based procedure coding, bundling policies specific to EMG/NCS and EEG, and FDA indication documentation for Botox and specialty treatments. Our AI-governed system ensures EMG/NCS billing matches documented muscles tested against coded extremity counts, validates EEG coding against continuous monitoring durations, and flags Botox billing for FDA indication compliance verification before submission. Real-time monitoring tracks neuropsychological testing documentation, and MS treatment planning to verify billing reflects appropriate complexity.
The Financial Impact of Neurology Billing Variance
A neurology practice with $4.5M annual revenue typically generates 30-40% of revenue from high-value diagnostic procedures.
At $1.35M-$1.8M annual procedure billing, underbilling from routine visit code selection represents 15-25% revenue loss or $202K-$450K annually.
Botox injection billing carries 14-18% denial rates when FDA indication documentation lacks payer specificity, creating $52K-$108K annual exposure.
Practices implementing complete neurology billing governance recover $200K-$400K annually, with EMG/NCS coding accuracy improvements alone recovering $120K-$240K annually.
Industry Benchmarks for Neurology Billing Performance
Stable organizations operate within these ranges:
Claim denial rate: under 4%
Clean claim rate on first submission: 91 to 96%
EMG/NCS coding accuracy: 94 to 98%
Accounts receivable days: Under 41
Botox/specialty injection indication documentation accuracy: 96 to 99%
Talk to a Revenue Cycle Expert
See how AI-enabled revenue governance can stabilize reimbursement and reduce denials for your organization.
Request a ConsultationWhere the Problem Starts
Practices apply routine visit coding to procedure-based encounters without understanding time-based procedure architecture.
An EMG/NCS encounter spanning 75 minutes generates $2.8K-$3.6K in proper procedure-based billing, but when billing staff apply established patient codes, billing drops to $180-$280, losing $2.5K-$3.3K per encounter.
Continuous EEG monitoring compounds this
As 48-72 hour monitoring requires component-level billing that many practices fail to separate, underbilling by 30-50%.
Botox and specialty treatment billing carries systematic FDA indication documentation
Failures when documentation lacks specific FDA indication language, resulting in payer denials regardless of clinical appropriateness.
How QWay Healthcare Controls Neurology Billing and Coding
EMG/NCS Component-Level Coding Architecture
We require documentation capturing number of extremities tested, muscles sampled, specific nerve conduction components performed, and electromyography needle placement locations.
Continuous EEG Monitoring Bundling and Time Tracking
For EEG monitoring exceeding 2 hours, we separate initial setup codes from continuous monitoring codes based on documented monitoring duration.
FDA Indication Documentation for Botox and Specialty Injections
We require documented FDA indication compliance before Botox billing advances to submission, including documentation of 15+ headache days monthly for chronic migraine.
Neuropsychological Testing Documentation and Indication Specificity
We verify that testing documentation includes the specific neuropsychological battery performed, testing duration, and clinical indication.
EEG Interpretation and Reporting Code Bundling Verification
Our system ensures EEG interpretation codes reflect the documented complexity of interpretation and reporting.
Multiple Sclerosis Treatment Plan Medical Decision-Making Documentation
For MS treatment planning, we verify that documentation reflects medical decision-making complexity.
Revenue Exposure Categories Addressed
- EMG/NCS routine visit coding underbilling from failure to apply component-level procedure codes
- Continuous EEG monitoring bundling errors from improper component separation and time tracking
- Botox and specialty injection denial from missing FDA indication documentation
- Neuropsychological testing underbilling from routine visit code application to distinct testing services
- EEG interpretation underbilling from simplified coding mismatches with documented interpretation complexity
Frequently Asked Questions
How much revenue can EMG/NCS underbilling cost a practice?
A 75-minute EMG/NCS encounter should generate $2.8K–$3.6K in proper procedure-based billing — but when billing staff apply routine established-patient codes instead, billing can drop to $180–$280, losing $2.5K–$3.3K per encounter.
What's a healthy denial rate for neurology billing?
Under 4%, with EMG/NCS coding accuracy of 94–98% and Botox/specialty injection indication documentation accuracy of 96–99%.
Why do Botox claims for migraine get denied so often?
Botox billing for migraine carries strict FDA indication requirements (including documentation of 15+ headache days monthly for chronic migraine) that payers enforce closely — off-label or under-documented use gets denied regardless of clinical appropriateness.
Why does continuous EEG monitoring often get underbilled?
48–72 hour monitoring requires component-level billing (separating initial setup from continuous monitoring codes) that many practices fail to separate correctly, leading to underbilling of 30–50%.